|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85.89 USD | -4.75% |
|
+11.27% | +12.29% |
| Market Cap | 16.84B 14.73B 13.58B 12.55B 23.81B 1,606B 24.21B 162B 63.74B 791B 63.22B 61.84B 2,720B | P/E 2026 * |
-39.2x | P/E 2027 * | 178x |
|---|---|---|---|---|---|
| Enterprise Value | 17.65B 15.44B 14.24B 13.15B 24.96B 1,684B 25.38B 170B 66.83B 829B 66.28B 64.84B 2,851B | EV / Sales 2026 * |
18.2x | EV / Sales 2027 * | 10.6x |
| Free-Float |
85.52% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BridgeBio Pharma, Inc.
| 1 day | -4.75% | ||
| 1 week | +11.27% | ||
| Current month | +15.32% | ||
| 1 month | +27.42% | ||
| 3 months | +15.15% | ||
| 6 months | +11.18% | ||
| Current year | +12.29% |
| 1 week | 76.01 |  | 93.42 |
| 1 month | 65.59 | | 93.42 |
| Current year | 62.5 | | 93.42 |
| 1 year | 42.09 | | 93.42 |
| 3 years | 16.79 | | 93.42 |
| 5 years | 4.98 | | 93.42 |
| 10 years | 4.98 | | 93.42 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | 75 | 01/04/2019 | |
Neil Kumar
CEO | Chief Executive Officer | 47 | 01/04/2015 |
Charles Homcy
PRN | Corporate Officer/Principal | 77 | 01/02/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Homcy
BRD | Director/Board Member | 77 | 01/11/2018 |
Eric Aguiar
BRD | Director/Board Member | 64 | 01/03/2019 |
James Momtazee
BRD | Director/Board Member | 54 | 01/03/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-24 | Fiscal year | Director | 111,501 | 0.0569% | ||
| 06-23 | Sell | Director | -2,196 | 0.0011% | ||
| 06-22 | Free | Director | 9,267 | 0.0047% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.75% | +11.27% | +85.63% | +394.76% | 16.84B | |
| -0.51% | +1.57% | +18.72% | -5.52% | 67.61B | |
| -5.16% | -8.63% | +37.37% | +202.27% | 51.6B | |
| +5.28% | +39.50% | +39.50% | +39.50% | 43B | |
| -2.10% | +0.89% | -49.30% | -53.47% | 40.94B | |
| +0.12% | -7.85% | +47.16% | -29.27% | 29.4B | |
| -10.83% | -14.41% | +99.15% | -44.54% | 27.09B | |
| -1.53% | -0.13% | +65.92% | +88.58% | 23.32B | |
| +3.88% | +2.16% | +11.78% | +201.51% | 19.89B | |
| -1.59% | -1.63% | +61.04% | +130.75% | 16.91B | |
| Average | -1.72% | -1.59% | +41.70% | +92.46% | 33.66B | |
| Weighted average by Cap. | -1.53% | -2.13% | +33.25% | +66.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 967M 846M 781M 721M 1.37B 92.27B 1.39B 9.33B 3.66B 45.46B 3.63B 3.55B 156B | 1.61B 1.41B 1.3B 1.2B 2.28B 153B 2.31B 15.51B 6.09B 75.62B 6.04B 5.91B 260B |
| Net income | -439M -384M -354M -327M -621M -41.89B -632M -4.23B -1.66B -20.64B -1.65B -1.61B -70.95B | 81.41M 71.21M 65.68M 60.67M 115M 7.76B 117M 785M 308M 3.83B 306M 299M 13.15B |
| Net Debt | 816M 714M 658M 608M 1.15B 77.81B 1.17B 7.86B 3.09B 38.33B 3.06B 3B 132B | 283M 247M 228M 211M 400M 26.97B 406M 2.73B 1.07B 13.28B 1.06B 1.04B 45.67B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | $85.89 | -4.75% | 6,382,515 |
| 09/07/26 | $90.17 | +15.12% | 20,327,218 |
| 08/07/26 | $78.33 | +0.54% | 2,060,863 |
| 07/07/26 | $77.91 | +0.21% | 2,694,509 |
| 06/07/26 | $77.75 | +0.73% | 3,137,228 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BBIO Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition